Saccharomyces cerevisiae

Saccharomyces cerevisiae is a single-celled eukaryote and a species of yeast of profound importance to humanity. It is a key agent in fermentation, responsible for the production of bread, beer, and wine. As a model organism in cell biology and genetics, it has been instrumental in numerous scientific breakthroughs, from understanding the cell cycle to pioneering synthetic biology. Its genome was the first from a eukaryote to be completely sequenced, cementing its status as a cornerstone of modern biological research.

Biology and genetics

Saccharomyces cerevisiae is a budding yeast that primarily reproduces asexually through a process called mitosis, where a smaller daughter cell forms on the parent cell. It is a facultative anaerobe, capable of generating energy through both aerobic respiration and anaerobic fermentation, with the latter producing ethanol and carbon dioxide. Its eukaryotic cell contains organelles such as the nucleus, mitochondria, and endoplasmic reticulum, making it an excellent model for studying fundamental cellular processes. The genome of the standard laboratory strain S288C was fully sequenced in 1996 by an international consortium, revealing approximately 12 million base pairs and around 6,000 genes. Landmark studies using it, such as those by Leland H. Hartwell and Paul Nurse, elucidated the genetic control of the cell cycle, work for which they shared the Nobel Prize in Physiology or Medicine. Its well-characterized genetics, including efficient homologous recombination, have made it a premier system for functional genomics and the development of tools like the yeast two-hybrid system.

History and domestication

The use of this yeast predates recorded history, with evidence of its role in ancient Egyptian bread-making and Mesopotamian beer production. For millennia, fermentation was a wild process, relying on ambient microbiota until the 19th century. A pivotal moment occurred in 1883 when Emil Christian Hansen, working at the Carlsberg Laboratory in Copenhagen, successfully isolated a pure culture, a technique that revolutionized the brewing industry. This allowed for the controlled propagation of specific strains, leading to the domestication of distinct lineages for winemaking, baking, and distilling. The Dutch East India Company likely facilitated the global spread of brewing strains during the Age of Discovery. The study of its genetics began in earnest with the work of Øjvind Winge at the Carlsberg Laboratory and was later advanced by researchers like Gerald R. Fink and David Botstein, who established its modern role in genetics.

Industrial and commercial uses

This yeast is a powerhouse of biotechnology and traditional industries. In baking, its fermentation of sugars produces carbon dioxide, which leavens dough. The brewing and winemaking industries rely on it to convert sugars in malt and grape must into ethanol and flavor compounds. Industrial bioethanol production utilizes strains engineered for high yield and tolerance. Beyond beverages, it is used to produce yeast extract, a flavor enhancer rich in glutamic acid, and as a source of nutritional yeast and beta-glucan supplements. It serves as a cellular factory for producing recombinant proteins, including insulin, hepatitis B vaccine, and enzymes for the food industry, leveraging platforms developed by companies like Novozymes and Genentech.

Role in scientific research

As a premier model organism, it has been foundational to discoveries in molecular biology and genetics. It was central to the identification of cyclin-dependent regulation of the cell cycle by Paul Nurse and Tim Hunt. The discovery of RNA splicing and the telomere replication mechanism by Elizabeth Blackburn and Carol Greider used this yeast system. It was the first eukaryote to have its genome fully sequenced, a project involving the Wellcome Trust and Stanford University. The Synthetic Yeast Genome Project (Sc2.0), an international effort led by Jef Boeke at New York University, aims to create a fully synthetic version of its genome. Its simple genetics and rapid growth make it ideal for high-throughput drug discovery screens and studies in systems biology.

Health and nutritional aspects

Nutritionally, inactive forms are sold as nutritional yeast, valued as a complete protein source and for its high B vitamin and mineral content. Some strains are used as probiotics, potentially supporting gut microbiota balance and immune system function. However, it can act as an opportunistic pathogen, particularly in immunocompromised individuals, causing conditions like fungemia. Research into its health effects is ongoing, with studies exploring its beta-glucan content for cholesterol management and immune modulation. It is generally recognized as safe by regulatory bodies like the U.S. Food and Drug Administration for use in food production.